Oxford Biomedica plc (OTCMKTS:OXBDF – Get Free Report) traded down 2.4% during mid-day trading on Thursday . The stock traded as low as $4.21 and last traded at $4.21. 30,000 shares changed hands during trading, an increase of 310% from the average session volume of 7,320 shares. The stock had previously closed at $4.31.
Oxford Biomedica Stock Performance
The company has a 50 day simple moving average of $4.34 and a 200-day simple moving average of $3.60.
Oxford Biomedica Company Profile
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Further Reading
- Five stocks we like better than Oxford Biomedica
- Overbought Stocks Explained: Should You Trade Them?
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- How Can Investors Benefit From After-Hours Trading
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Investing in Construction Stocks
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.
